ArticleStem cells translational medicine2019

Phenotypic Drug Screening for Dysferlinopathy Using Patient-Derived Induced Pluripotent Stem Cells.

Yuko Kokubu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.